Insulet (PODD) stock in plain English
Every company we rate gets Strong Buy, Buy, Buy with Caution, Hold or Sell. Members see the rating for this company and the five scores behind it.
Change shown by the quote provider. Data may be delayed.
What does Insulet (PODD) do?
Insulet Corp (PODD) is a U.S.-listed company in Healthcare (Medical Devices). What it does: Produces wearable, tubeless insulin delivery devices and digital management software for people with diabetes. Manufactures tubeless, wearable insulin pods that eliminate external catheters for continuous diabetes management. It is worth $9.52B on the market and sold $3.18B over the last year.
- Market cap
- $9.52B
- P/E ratio
- 23.5×
- Annual sales
- $3.18B
- Sector
- Healthcare
- Industry
- Medical Devices
- Brief updated
- Nov 12, 2026
Brands and businesses behind PODD
- Omnipod: Sells wearable disposable insulin pods and controllers that generate revenue through ongoing pharmacy prescription refills.
PODD’s flags, in plain English
Each flag is a number from Insulet’s reports to the SEC or from market data, with the reason it matters. This brief was updated on Nov 12, 2026.
Wide Gross Margin
Gross margin of 72.9% after the cost of making its products. There is a large gap between what its products cost to make and what they sell for, and that gap pays for everything else.
Earns Its Keep
Earns 28.9% a year on shareholders' money. The company earns a healthy return on the money its shareholders have put in.
Still Climbing
Sales up 24.5% a year over 5 years. Sales are higher than a year ago. Growth does not guarantee profit, so look at the margins too.
Worth a Look
Competing medical technology companies sell automated insulin delivery pumps and integrated sensors that create pricing and market share pressure. Something here could change the picture, so it is worth reading next to the good news.
2 more green flags open with the free trial. Try it free for 7 days.
Questions about PODD
How big is Insulet?
Insulet’s market cap is $9.52B: what all of its shares are worth together at today’s price. Its annual sales (revenue) are $3.18B: what customers paid the company over the last year, before any costs.
What is PODD’s P/E ratio?
PODD’s P/E ratio is 23.5×. Investors pay about 23.5 dollars for each dollar of the company’s yearly profit. A low number can mean a bargain or a problem, so read it next to the flags.
What could go wrong with PODD?
The first risk note on the card is Worth a Look, explained above. A flag reads what the company reported. It does not predict the price.
Where do these numbers come from?
From Insulet’s own reports to the SEC (annual and quarterly) and from market data. Every company runs through the same scoring formula, and a reviewer spot-checks cards against the source data. PODD’s filings on SEC.gov. The Margin Monkey is research, not advice.
